Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
Funding Amount
$700,000 total
Deadline
Forecast — dates not yet posted
Number of Awards
1
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Small businesses
- City & township governments
- County governments
- Private colleges & universities
- Nonprofits (501(c)(3))
- Tribal organizations
- State governments
- Tribal governments
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Not eligible / not funded
- Not eligible: This NOFO will utilize the {U01 Clinical Trial Not Allowed Cooperative Agreement} activity code.
Overview
The NIDDK, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on collecting and analyzing data from clinical trials involving isolated human islets as a treatment for diabetes. This data will be used by research community for publications and presentations and to help design future clinical trials. Additionally, CITR will prepare periodic reports summarizing islet transplantation outcomes and trends overs time to inform the public. Additionally, CITR will conduct periodic meetings of the contributing sites. Applications are not being solicited currently. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the {U01 Clinical Trial Not Allowed Cooperative Agreement} activity code. Investigators with expertise and insights into this area of {Clinical Trial Data Collection} are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in {Data Analyses} will be encouraged and these investigators should also begin considering applying for this NOFO.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-DK-27-106
- Total Funding: $700,000
- Expected Awards: 1
- Instrument: cooperative_agreement
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Healthcare
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed). Now let's win it.